Table 1.

Patient characteristics, monitoring and functional outcome

Patient No.	Age range	Comorbidity	SAB grade (WFNS)	Aneurysm location	Side	Probe placement	SEP monitoring	Pathological SEP?	Vasospasm/related neurological deficite?	mRS at discharge	mRS at 12 months
1	3	AH	V	AcoA	L	temporal	Posterior tibial nerve	yes	no	5	4
2	2	AH	II	ACA	R	temporal	n.a.	n.a.	yes/no	1	1
3	2	AH	III	AcoA	L	frontal	Posterior tibial nerve	yes	yes/no	2	1
4	1	none	II	ACA	R	temporal	Posterior tibial nerve	no	yes/no	0	0
5	3	none	IV	AcoA	R	frontal	Posterior tibial nerve	yes	no	2	1
6	2	AH	II	MCA	R	temporal	Median nerve	no	no	2	2
7	1	none	IV	MCA	L	temporal	Median nerve	yes	no	3	3
8	3	AH	II	AcoA	L	temporal	Posterior tibial nerve	no	no	1	0
9	3	AH	V	AcoA	L	frontal	Posterior tibial nerve	yes	yes/yes	6	6
10	2	AH	III	MCA	R	temporal	Median nerve	yes	yes/no	4	4
11	3	AH	IV	MCA	R	temporal	Median nerve	no	yes/no	1	0
12	4	AH, CAD, HI	V	MCA	L	temporal	n.a.	n.a.	no	6	6
13	2	AH	II	MCA	R	frontal	Median nerve	yes	yes/no	1	1
14	1	AH	III	MCA	L	temporal	Median nerve	yes	yes/yes	3	3

Age range (years) 1 = 40–49, 2 = 50–59, 3 = 60–69, 4 = 80–85. AcoA anterior communicating artery, ACA anterior cerebral artery, MCA middle cerebral artery, AH arterial hypertension, CAD coronary artery disease, HI heart insufficiency, mRS modified Rankin Scale, WFNS World Federation of Neurosurgical Societies